Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study

Abstract Objective Recent preclinical and retrospective clinical evidence shows that androgen receptor (AR)-mediated signals have significant roles in development of non-muscle invasive bladder cancer (NMIBC). Here, we conducted a single-center, phase I study to assess the feasibility and efficacy o...

Full description

Saved in:
Bibliographic Details
Main Authors: Takashi Kawahara, Shuya Kandori, Takahiro Kojima, Bryan J. Mathis, Masanobu Shiga, Hiroyuki Nishiyama
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Research Notes
Subjects:
Non-muscle invasive bladder cancer
Enzalutamide
Androgen receptor
Phase 1 study
Online Access:https://doi.org/10.1186/s13104-025-07128-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13104-025-07128-z

Similar Items